10235532

Source:http://linkedlifedata.com/resource/pubmed/id/10235532

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0001554, umls-concept:C0030705, umls-concept:C0040395, umls-concept:C0233929, umls-concept:C0346647, umls-concept:C0750491, umls-concept:C1273870
pubmed:issue	5
pubmed:dateCreated	1999-6-7
pubmed:abstractText	To assess the accuracy and clinical impact of 18fluorodeoxyglucose-positron emission tomography (18FDG-PET) on the management of patients with suspected primary or recurrent pancreatic adenocarcinoma, and to assess the utility of 18FDG-PET in grading tumor response to neoadjuvant chemoradiation.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/CA74773
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/10235532-1432158, http://linkedlifedata.com/resource/pubmed/commentcorrection/10235532-1584912, http://linkedlifedata.com/resource/pubmed/commentcorrection/10235532-1681794, http://linkedlifedata.com/resource/pubmed/commentcorrection/10235532-189189, http://linkedlifedata.com/resource/pubmed/commentcorrection/10235532-2372287, http://linkedlifedata.com/resource/pubmed/commentcorrection/10235532-2789238, http://linkedlifedata.com/resource/pubmed/commentcorrection/10235532-3180054, http://linkedlifedata.com/resource/pubmed/commentcorrection/10235532-7518342, http://linkedlifedata.com/resource/pubmed/commentcorrection/10235532-7698152, http://linkedlifedata.com/resource/pubmed/commentcorrection/10235532-7724750, http://linkedlifedata.com/resource/pubmed/commentcorrection/10235532-7724751, http://linkedlifedata.com/resource/pubmed/commentcorrection/10235532-7797130, http://linkedlifedata.com/resource/pubmed/commentcorrection/10235532-7907464, http://linkedlifedata.com/resource/pubmed/commentcorrection/10235532-8208970, http://linkedlifedata.com/resource/pubmed/commentcorrection/10235532-8355920, http://linkedlifedata.com/resource/pubmed/commentcorrection/10235532-8418248, http://linkedlifedata.com/resource/pubmed/commentcorrection/10235532-8554144, http://linkedlifedata.com/resource/pubmed/commentcorrection/10235532-8626891, http://linkedlifedata.com/resource/pubmed/commentcorrection/10235532-8653677, http://linkedlifedata.com/resource/pubmed/commentcorrection/10235532-8683297, http://linkedlifedata.com/resource/pubmed/commentcorrection/10235532-8942539, http://linkedlifedata.com/resource/pubmed/commentcorrection/10235532-9024707, http://linkedlifedata.com/resource/pubmed/commentcorrection/10235532-9169578, http://linkedlifedata.com/resource/pubmed/commentcorrection/10235532-9255148, http://linkedlifedata.com/resource/pubmed/commentcorrection/10235532-9293783, http://linkedlifedata.com/resource/pubmed/commentcorrection/10235532-9293784, http://linkedlifedata.com/resource/pubmed/commentcorrection/10235532-9494412, http://linkedlifedata.com/resource/pubmed/commentcorrection/10235532-9494496, http://linkedlifedata.com/resource/pubmed/commentcorrection/10235532-9494497, http://linkedlifedata.com/resource/pubmed/commentcorrection/10235532-9506364, http://linkedlifedata.com/resource/pubmed/commentcorrection/10235532-9527052, http://linkedlifedata.com/resource/pubmed/commentcorrection/10235532-9527053, http://linkedlifedata.com/resource/pubmed/commentcorrection/10235532-9529287, http://linkedlifedata.com/resource/pubmed/commentcorrection/10235532-9605668, http://linkedlifedata.com/resource/pubmed/commentcorrection/10235532-9605913, http://linkedlifedata.com/resource/pubmed/commentcorrection/10235532-9635805
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0372354
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Fluorodeoxyglucose F18, http://linkedlifedata.com/resource/pubmed/chemical/Radiopharmaceuticals
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	0003-4932
pubmed:author	pubmed-author:BeauchampR DRD, pubmed-author:ChapmanW CWC, pubmed-author:DelbekeDD, pubmed-author:FrexesM EME, pubmed-author:MILLSMM, pubmed-author:PinsonC WCW, pubmed-author:RichardsW OWO, pubmed-author:RoseD MDM, pubmed-author:SandlerM PMP, pubmed-author:SharpK WKW, pubmed-author:WrightJ KJK
pubmed:issnType	Print
pubmed:volume	229
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	729-37; discussion 737-8
pubmed:dateRevised	2009-11-18
pubmed:meshHeading	pubmed-meshheading:10235532-Adenocarcinoma, pubmed-meshheading:10235532-Fluorodeoxyglucose F18, pubmed-meshheading:10235532-Humans, pubmed-meshheading:10235532-Pancreatic Neoplasms, pubmed-meshheading:10235532-Predictive Value of Tests, pubmed-meshheading:10235532-Radiopharmaceuticals, pubmed-meshheading:10235532-Reproducibility of Results, pubmed-meshheading:10235532-Sensitivity and Specificity, pubmed-meshheading:10235532-Tomography, Emission-Computed
pubmed:year	1999
pubmed:articleTitle	18Fluorodeoxyglucose-positron emission tomography in the management of patients with suspected pancreatic cancer.
pubmed:affiliation	Department of Surgery, Vanderbilt University Medical Center, the Vanderbilt Cancer Center, Nashville, Tennessee 37232-2736, USA.
pubmed:publicationType	Journal Article, Clinical Trial, Research Support, U.S. Gov't, P.H.S., Review